Correlation Between Biotechnology Portfolio and Fidelity Advisor

Can any of the company-specific risk be diversified away by investing in both Biotechnology Portfolio and Fidelity Advisor at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biotechnology Portfolio and Fidelity Advisor into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Biotechnology Portfolio Biotechnology and Fidelity Advisor Health, you can compare the effects of market volatilities on Biotechnology Portfolio and Fidelity Advisor and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biotechnology Portfolio with a short position of Fidelity Advisor. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biotechnology Portfolio and Fidelity Advisor.

Diversification Opportunities for Biotechnology Portfolio and Fidelity Advisor

0.72

Correlation Coefficient

Biotechnology Portfolio  Fidelity Advisor

Poor diversification

The 3 months correlation between Biotechnology and Fidelity is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Biotechnology Portfolio Biotec and Fidelity Advisor Health in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fidelity Advisor Health and Biotechnology Portfolio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biotechnology Portfolio Biotechnology are associated (or correlated) with Fidelity Advisor. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fidelity Advisor Health has no effect on the direction of Biotechnology Portfolio i.e., Biotechnology Portfolio and Fidelity Advisor go up and down completely randomly.

Pair Corralation between Biotechnology Portfolio and Fidelity Advisor

Assuming the 90 days horizon Biotechnology Portfolio Biotechnology is expected to under-perform the Fidelity Advisor. In addition to that, Biotechnology Portfolio is 1.46 times more volatile than Fidelity Advisor Health. It trades about -0.07 of its total potential returns per unit of risk. Fidelity Advisor Health is currently generating about -0.08 per unit of volatility. If you would invest  7,671  in Fidelity Advisor Health on September 14, 2024 and sell it today you would lose (329.00) from holding Fidelity Advisor Health or give up 4.29% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Biotechnology Portfolio Biotec  vs.  Fidelity Advisor Health

Biotechnology Portfolio

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Biotechnology Portfolio Biotechnology has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong basic indicators, Biotechnology Portfolio is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Fidelity Advisor Health

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Fidelity Advisor Health has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong fundamental indicators, Fidelity Advisor is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Biotechnology Portfolio and Fidelity Advisor

The main advantage of trading using opposite Biotechnology Portfolio and Fidelity Advisor positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biotechnology Portfolio position performs unexpectedly, Fidelity Advisor can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fidelity Advisor will offset losses from the drop in Fidelity Advisor's long position.

The idea behind Biotechnology Portfolio Biotechnology and Fidelity Advisor Health pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.